Northwest Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.04	2.18	2.13	6.97	15.17
Cash & Short-Term Investments	3.04	2.18	2.13	6.97	15.17
Cash Growth	39.77%	2.31%	-69.48%	-54.08%	51.95%
Receivables	0.31	-	-	-	-
Prepaid Expenses	2.17	1.89	2	2.46	2.12
Total Current Assets	5.52	4.06	4.13	9.43	17.29
Property, Plant & Equipment	21.6	20.38	21.46	19.64	19.92
Goodwill	0.63	0.63	0.63	0.63	0.63
Other Intangible Assets	53.19	1.29	1.29	1.29	1.29
Other Long-Term Assets	0.36	0.37	0.36	0.35	1.04
Total Assets	81.29	26.73	27.87	31.32	40.16
Accounts Payable	30.82	16.97	10.24	10.69	6.98
Accrued Expenses	-	4.45	-	-	-
Short-Term Debt	9.47	14.19	3.94	15.4	7.1
Current Portion of Long-Term Debt	32.7	20.19	16.54	0.14	0.14
Current Portion of Leases	0.37	0.33	0.31	0.35	0.32
Other Current Liabilities	18.35	12.15	14.17	99.43	119.24
Total Current Liabilities	91.7	68.27	45.2	126.01	133.77
Long-Term Debt	17.88	28.3	20.31	5.99	25.16
Long-Term Leases	4.41	4.44	4.45	4.37	5.23
Long-Term Deferred Tax Liabilities	13.17	-	-	-	-
Other Long-Term Liabilities	1.7	4.7	4.95	-	-
Total Liabilities	128.86	105.71	74.92	136.37	164.15
Common Stock	1.57	1.33	1.18	1.07	0.95
Additional Paid-In Capital	1,443	1,345	1,291	1,165	1,067
Retained Earnings	-1,504	-1,443	-1,360	-1,297	-1,192
Treasury Stock	-0.01	-	-	-	-
Comprehensive Income & Other	-1	2.96	1.46	3.07	0.28
Total Common Equity	-60.28	-94.49	-65.77	-128.1	-123.99
Shareholders' Equity	-47.57	-78.98	-47.06	-105.04	-123.99
Total Liabilities & Equity	81.29	26.73	27.87	31.32	40.16
Total Debt	64.83	67.44	45.56	26.25	37.94
Net Cash (Debt)	-61.79	-65.27	-43.43	-19.29	-22.77
Net Cash Per Share	-0.04	-0.05	-0.04	-0.02	-0.02
Filing Date Shares Outstanding	1,607	1,391	1,190	1,073	960.02
Total Common Shares Outstanding	1,567	1,329	1,176	1,068	948.45
Working Capital	-86.18	-64.21	-41.08	-116.58	-116.48
Book Value Per Share	-0.04	-0.07	-0.06	-0.12	-0.13
Tangible Book Value	-114.09	-96.41	-67.69	-130.02	-125.91
Tangible Book Value Per Share	-0.07	-0.07	-0.06	-0.12	-0.13
Land	0.09	0.09	0.09	0.08	0.09
Machinery	5.92	3.69	3.26	2.54	2.11
Construction In Progress	-	-	-	2.03	-
Leasehold Improvements	19.08	17.97	17.79	13.07	13.91

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.